Paul Gilman
Hematology & Oncology · Wynnewood, PANPI 1215943634
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $681 of the $840 with a category attached, or 81.0%. 11 manufacturers reported payments, led by Bristol Myers Squibb at 25.7% of the total. Reporting peaked in 2019 at $568 and has fallen 86.3% since, to $78 in 2022. That places this record below the midpoint for hematology & oncology clinicians in PA, where the typical reported total is $1,277.
Across 37 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$216
- Servier Pharmaceuticals LLC$159
- Genentech USA, Inc.$127
- Eisai Inc.$127
- Johnson & Johnson$47
- Lilly USA, LLC$44
- plus $121 from 5 others
Across 115 payments — averaging $4196.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Tolmar, Inc.$135K
- Merck$127K
- Sanofi US Services Inc.$71K
- Genentech, Inc.$46K
- GSK$34K
- Radius Health, Inc.$22K
- plus $47K from 4 others
What the payments were for
- Food & beverage$68181%
- Education$15919%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 8 | $216 |
| Servier Pharmaceuticals LLC | 4 | $159 |
| Genentech USA, Inc. | 8 | $127 |
| Eisai Inc. | 6 | $127 |
| Johnson & Johnson | 2 | $47 |
| Lilly USA, LLC | 3 | $44 |
| Merck | 2 | $35 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $30 |
| AVEO Pharmaceuticals, Inc. | 1 | $22 |
| Seagen Inc. | 1 | $18 |
| Astellas Pharma US Inc | 1 | $15 |
How this compares
$840 in reported general payments places this provider in the 40th percentile of 682 hematology & oncology providers in Pennsylvania.
Other hematology & oncology in Wynnewood
- Salman FazalPittsburgh$2.3M
- Cyrus KhanPittsburgh$1.9M
- Usama GergisAllentown$1.2M
- Kit LuHarrisburg$810K
- Henry FungPhiladelphia$730K
- Alexander BarsoukPittsburgh$674K
- Abdalla SholiWilliamsport$576K
- Charu AggarwalPhiladelphia$541K
- Tracey EvansEast Norriton$500K
- Corey LangerPhiladelphia$492K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.